Patents Assigned to Roche Diagnostics Operations, Inc.
  • Patent number: 11099180
    Abstract: The disclosure concerns a method and kits for measurement of an analyte in a microparticle-based analyte-specific binding assay. In the assay, the microparticles are coated with the first partner of a binding pair, mixing the coated microparticles and at least two analyte-specific binding agents, each conjugated to the second partner of the binding pair, and a sample suspected of containing the analyte. The second partner of the binding pair is bound to each of the analyte-specific binding agents via a linker comprising from 12 to 30 ethylene glycol units (PEG 12 to 30), thereby binding the analyte via the conjugated analyte-specific binding agents to the coated microparticles. The method also entails separating the microparticles having the analyte bound via the binding pair and the analyte-specific binding agent from the mixture and measuring the analyte bound to the microparticles.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: August 24, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Ralf Bollhagen, Barbara Upmeier, Werner Naser, Toralf Zarnt
  • Patent number: 11099149
    Abstract: A test element for electrochemically detecting at least one analyte in a bodily fluid is disclosed. The test element comprises at least one first electrode and at least one second electrode. The first electrode is designed as a working electrode and the second electrode is designed as a counter electrode. The test element comprises at least one capillary capable of receiving a sample of the body fluid. The first electrode and the second electrode are arranged on opposing sides of the capillary. The first electrode and the second electrode are arranged such that during a capillary filling the first electrode and the second electrode are wetted simultaneously and at an equal rate.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: August 24, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Klaus Andreas Bauer-Espindola, Michael Marquant, Christine Nortmeyer, Reiner Stein
  • Patent number: 11092612
    Abstract: A system for dispensing vessels to an analyzer is disclosed. The system comprises a disc rotatable about an axis and comprising a groove, a drum arranged above and coupled to the disc to rotatable together about the axis, the drum comprising slots arranged along and around the axis, each slot comprising an input interface for stacking vessels in the slot and an output interface for dispensing the vessels, the output interface comprising a retainer, a crank translatable in a linear forwards and backwards direction orthogonal to the axis between a first, second, and third position. The crank comprises a pin for rotating the disc and bringing a slot into a dispensing position upon translation between the first and second position, the crank comprising an actuator pin for actuating the retainer in the dispensing position upon translation of the crank between the second and third position to dispense the vessels.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: August 17, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Thomas Guggisberg, Christian Marty, Jan Simon Portmann, Gottlieb Schacher, Rolf Schneebeli, Markus Troxler, Beat Rene Widmer, Urs Wittenwiler
  • Patent number: 11092613
    Abstract: A method of operating a laboratory sample distribution system is presented. The laboratory sample distribution system comprises a number of sample container carriers. The sample container carriers are adapted to carry one or more sample containers. The sample containers comprise samples to be analyzed by a number of laboratory stations. The laboratory sample distribution system also comprises a transport plane. The transport plane is adapted to support the sample container carriers. The method comprises allocating an area of the transport plane as a buffer area. The buffer area is adapted to store a variable number of sample container carriers. The method also comprises controlling the buffer area using a puzzle-based control scheme or using an aisle-based control scheme as a function of a storage density of the buffer area.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: August 17, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Mohammadreza Mahmudimanesh, Sophia Bruntsch, Soraya Garcia Bustos, Walter Ebner, Shubin Ren, Mohsin Reza, Daniel Diez Diaz-Calonge
  • Patent number: 11078511
    Abstract: The present disclosure is directed to the properties of certain glycosyltransferase variants having N-terminal truncation deletions or internal deletions. Any of the mutants disclosed in here exhibit alpha-2,6-sialyltransferase enzymatic activity in the presence of CMP-activated sialic acid as co-substrate, and in the presence of a suitable acceptor site. A fundamental finding documented in the present disclosure is that these enzymes are not only capable of catalyzing transfer of a sialidyl moiety but they are also capable of catalyzing hydrolytic cleavage of terminally bound sialic acid from a glycan.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: August 3, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Harald Sobek, Michael Greif, Marco Thomann, Sebastian Malik
  • Patent number: 11078545
    Abstract: The present disclosure provides a method and system for the PCR amplification of a target sequence which suppresses non-specific amplification products. The disclosure concerns the use of a primer pair optimized to amplify a nucleic acid of a contaminant in the background of genomic DNA of a first organism. When DNA from a second organism suspected for comprising the contaminant is subjected to the same PCR-based amplification reaction, detection sensitivity and specificity of the contaminant is enhanced when an amount of genomic DNA of the first organism is present in the amplification reaction.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: August 3, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Christian Birkner
  • Patent number: 11078241
    Abstract: The disclosure relates to a multi-epitope fusion protein as well as to its use as calibrator and/or control in an in vitro diagnostics immunoassay for detecting HCV core antigen. The multi-epitope fusion protein has two to six different non-overlapping linear peptides present in the amino acid sequence of hepatitis C virus (HCV) core protein, wherein each of the peptides is separated from the other peptides by a spacer consisting of a non-HCV amino acid sequence and having a chaperone amino acid sequence. No further HCV specific amino acid sequences are present in the polypeptide. A further aspect relates to a reagent kit for detecting HCV core antigen containing said multi-epitope fusion protein as calibrator or control or both.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: August 3, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Barbara Upmeier, Ralf Bollhagen, Toralf Zarnt
  • Publication number: 20210231641
    Abstract: A method for determining properties of a laboratory sample contained in a laboratory sample container is presented. The method comprises measuring projections of the laboratory sample container comprising the laboratory sample by irradiating light to the laboratory sample container at different projection angle and determining the properties by tomographic reconstruction based on the projections.
    Type: Application
    Filed: April 15, 2021
    Publication date: July 29, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventor: Michael Rein
  • Publication number: 20210215716
    Abstract: The present invention relates to a method for assessing atrial fibrillation in a subject, said method comprising the steps of determining the amount of SPON-1 in a sample from the subject, and comparing the amount of SPON-1 to a reference amount, whereby atrial fibrillation is to be assessed. Moreover, the present invention relates to methods for the prediction of stroke based on the amount of SPON-1.
    Type: Application
    Filed: February 22, 2021
    Publication date: July 15, 2021
    Applicants: Roche Diagnostics Operations, Inc., Universiteit Maastricht, Academisch Ziekenhuis Maastricht
    Inventors: Peter Kastner, Manuel Dietrich, André Ziegler, Ursula-Henrike Wienhues-Thelen, Vinzent Rolny, Ulrich Schotten
  • Publication number: 20210215731
    Abstract: A computer-implemented method for processing biological samples in an environment including multiple automated analyzers having multiple modules is presented. The method includes receiving data related to a plurality of orders for processing biological samples at a main workflow engine. The main workflow engine receives and processes data for each of the multiple automated analyzers having multiple modules. The method further includes providing a data snapshot to at least one shadow workflow engine associated with a subset of one or more modules of the multiple modules. The data snapshot comprises only a portion of the data related to the plurality of orders that is necessary to determine actions of the module of the multiple modules. The method further includes determining, by the shadow workflow engine, a plurality of actions for the subset of modules to process the plurality of orders based on the data snapshot.
    Type: Application
    Filed: January 6, 2021
    Publication date: July 15, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Alejandro Morcillo Montejo, Marco Maetzler, Juan Bacardit
  • Publication number: 20210213450
    Abstract: A method to process a laboratory carrier in a laboratory system based on a feature of a test liquid in the laboratory carrier is presented. The laboratory system comprises the laboratory carrier comprising the test liquid, a terahertz wave source, a terahertz detector, a laboratory carrier processing device, and a control unit. Using terahertz technology and data analysis, the feature of the test liquid in the laboratory carrier can be determined. In addition, the control unit controls the laboratory carrier processing device based on the determined feature of the test liquid.
    Type: Application
    Filed: January 5, 2021
    Publication date: July 15, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Andreas Drechsler, Darko Klinec, Michael Koehler, Alexander Jakob, Michael Zeder
  • Publication number: 20210206793
    Abstract: The present invention relates to crystalline (thio)nicotinamide ribofuranoside salts, methods of making such crystalline salts, a pharmaceutical composition comprising same, and use of said crystalline salts as nutritional (dietary) supplements. Furthermore, the present invention relates to a composition comprising amorphous (thio)nicotinamide ribofuranoside salts and its use as nutritional (dietary) supplement.
    Type: Application
    Filed: May 17, 2019
    Publication date: July 8, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Urs SPITZ, Günter SCHABERT, Aysel SOYDEMIR, Lukas WICK
  • Patent number: 11047865
    Abstract: Method for determination of whether a subject suffers from intermittent atrial fibrillation based on the determination of the amount of a Troponin T in a sample in a patient suffering from atrial fibrillation using a binding assay. Kits and devices adapted to carry out the methods are also provided.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: June 29, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Georg Hess, Andrea Horsch, Dietmar Zdunek
  • Patent number: 11047866
    Abstract: Presented is a method for diagnosing and/or grading diastolic dysfunction or at least one structural or functional abnormality associated with diastolic dysfunction. The method involves measuring the level of IGFBP7 (Insulin like growth factor binding protein 7) and, optionally, the level of at least one further marker in a patient suffering from heart failure, and comparing the level to a reference level. Further envisaged is a method of monitoring diastolic function in a patient suffering from heart failure. Also described are kits and devices adapted to carry out the method.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: June 29, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Johann Karl, Ursula-Henrike Wienhues-Thelen, Dirk Block, Christian Zaugg, Hans-Peter Brunner, James Januzzi, Andre Ziegler, Julian Braz, Thomas Dieterle, Edelgard Kaiser
  • Patent number: 11047871
    Abstract: A centering unit for diagnostics laboratory transporting compartment is presented. The centering unit for diagnostics laboratory transporting compartment comprises at least two arms with grippers for centering diagnostics laboratory transporting compartments of different diameters. For accurate and reliable centering of laboratory transporting compartments, the two arms are biased with a single elastic member. A laboratory system and a method for centering diagnostics laboratory transporting compartment and diagnostics laboratory transporting compartment holder are also disclosed.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: June 29, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Daniel Arnold, Fabian Wenzler
  • Publication number: 20210190802
    Abstract: A method to optimize analyzer use in a laboratory having a plurality of analyzers based on laboratory workload is presented. The method comprises determining current laboratory workload, calculating workload capability of the plurality of analyzers minus one analyzer if the current laboratory workload is below a threshold criteria and if there are two or more analyzers in the plurality of analyzers, masking one of the plurality of analyzers if the current workload is met by the plurality of analyzers minus one analyzer, proceeding with current workload, and repeating the above steps until the current laboratory workload has been completed.
    Type: Application
    Filed: December 11, 2020
    Publication date: June 24, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventor: Marco Maetzler
  • Publication number: 20210192265
    Abstract: A method of assessing the suitability of at least one sample tube for use in a laboratory automation system is disclosed. The method comprises capturing at least one image of at least a part of the sample tube by using a camera of a mobile device, obtaining at least one first item of identification information of the sample tube by analyzing the image, retrieving at least one second item of identification information of the sample tube, and evaluating the first and second items of identification information and assigning the sample tube to at least one suitability category. A mobile device and an assessment system for assessing the suitability of at least one sample tube for use in a laboratory automation system are also disclosed.
    Type: Application
    Filed: December 11, 2020
    Publication date: June 24, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventor: Timo Fleischmann
  • Publication number: 20210190736
    Abstract: A method for monitoring an analyzer including a liquid chromatography device (LC) having at least two liquid chromatography (LC) streams, the method including continuously monitoring one or more parameters in measurement data of samples in each of the at least two LC streams, the one or more parameters being independent of an analyte concentration of the respective sample, determining if the one or more monitored parameters show an expected behavior and triggering a response upon detection that the one or more monitored parameters deviate from the expected behavior.
    Type: Application
    Filed: December 7, 2020
    Publication date: June 24, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Albert Geiger, Daniel Intelmann, Ruediger Laubender, Julian Michely, Kirill Tarasov
  • Patent number: 11041846
    Abstract: A test element analysis system for the analytical examination of a sample is disclosed. The test element analysis system comprises: at least one evaluation device with at least one test element holder for positioning a test element containing the sample and at least one measuring device for measuring a change in a measuring zone of the test element, the change being characteristic for the analyte; at least one electrical heating element configured for electrically heating the test element; at least one electrical power supply for supplying electrical energy to the electrical heating element; at least one temperature sensor connected to the test element holder for detecting a temperature of the test element holder; at least one gap detection device configured for monitoring the electrical energy Espez supplied by the electrical power supply to the electrical heating element for reaching a predetermined target temperature measured by the temperature sensor.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: June 22, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Kai Hebestreit, Sylvia Saecker, Klaus Thome, Andreas Weller, Robert Knapstein, Werner Heidt, Stefan Lieder
  • Publication number: 20210181166
    Abstract: An analytical system including a mass spectrometer (MS) coupled to liquid chromatography (LC) via an ionization source (IS), and an automated method of maintaining the analytical system in a QC-compliant status are described. The method comprises determining a deviation of the analytical system from a QC-compliant status by determining a deviation of one or more predetermined parameters in an m/z spectrum above one or more predetermined thresholds, triggering an IS and/or MS maintenance procedure upon determining a deviation from the QC-compliant status, determining a return or a failed return to the QC-compliant status during and/or after the IS and/or MS maintenance procedure by determining a return or a failed return respectively of the one or more predetermined parameters in an m/z spectrum below the one or more predetermined thresholds, triggering another IS and/or MS maintenance procedure upon determining a failed return to the QC-compliant status.
    Type: Application
    Filed: December 7, 2020
    Publication date: June 17, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Stefan Quint, Marian Roetzer, Florian Schweinberger, Benjamin Tiemann, Marius Wagner, Ralf Zimmermann